Cargando…
Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974934/ https://www.ncbi.nlm.nih.gov/pubmed/36854661 http://dx.doi.org/10.1038/s41392-022-01292-5 |
| _version_ | 1784898781055025152 |
|---|---|
| author | Cheng, Binbin Wang, Wei Liu, Ting Cao, Hao Pan, Wei Xiao, Yao Liu, Shuwen Chen, Jianjun |
| author_facet | Cheng, Binbin Wang, Wei Liu, Ting Cao, Hao Pan, Wei Xiao, Yao Liu, Shuwen Chen, Jianjun |
| author_sort | Cheng, Binbin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9974934 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99749342023-03-02 Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment Cheng, Binbin Wang, Wei Liu, Ting Cao, Hao Pan, Wei Xiao, Yao Liu, Shuwen Chen, Jianjun Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-03-01 /pmc/articles/PMC9974934/ /pubmed/36854661 http://dx.doi.org/10.1038/s41392-022-01292-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Cheng, Binbin Wang, Wei Liu, Ting Cao, Hao Pan, Wei Xiao, Yao Liu, Shuwen Chen, Jianjun Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment |
| title | Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment |
| title_full | Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment |
| title_fullStr | Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment |
| title_full_unstemmed | Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment |
| title_short | Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment |
| title_sort | bifunctional small molecules targeting pd-l1/cxcl12 as dual immunotherapy for cancer treatment |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974934/ https://www.ncbi.nlm.nih.gov/pubmed/36854661 http://dx.doi.org/10.1038/s41392-022-01292-5 |
| work_keys_str_mv | AT chengbinbin bifunctionalsmallmoleculestargetingpdl1cxcl12asdualimmunotherapyforcancertreatment AT wangwei bifunctionalsmallmoleculestargetingpdl1cxcl12asdualimmunotherapyforcancertreatment AT liuting bifunctionalsmallmoleculestargetingpdl1cxcl12asdualimmunotherapyforcancertreatment AT caohao bifunctionalsmallmoleculestargetingpdl1cxcl12asdualimmunotherapyforcancertreatment AT panwei bifunctionalsmallmoleculestargetingpdl1cxcl12asdualimmunotherapyforcancertreatment AT xiaoyao bifunctionalsmallmoleculestargetingpdl1cxcl12asdualimmunotherapyforcancertreatment AT liushuwen bifunctionalsmallmoleculestargetingpdl1cxcl12asdualimmunotherapyforcancertreatment AT chenjianjun bifunctionalsmallmoleculestargetingpdl1cxcl12asdualimmunotherapyforcancertreatment |